Lisa Shulman is director of autism clinical services at the Children’s Evaluation and Rehabilitation Center at Montefiore Medical Center in New York City.
Lisa Shulman
Director of autism clinical services
Children’s Evaluation and Rehabilitation Center, Montefiore Medical Center
From this contributor
How to help underserved groups gain access to autism care
Place your autism center in the community you serve, remove barriers to care, cast a wide net for autism signs, and do as much as possible in the first visit: These principles can help build a lifelong relationship with the community.
How to help underserved groups gain access to autism care
By
Lisa Shulman
15 January 2019 | 6 min read
Children who ‘recover’ from autism still struggle
Some children with autism lose their diagnosis over time, but still struggle with language, learning and anxiety, says Lisa Shulman.
Explore more from The Transmitter
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
By
The Transmitter
24 December 2025 | 2 min read
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
By
The Transmitter
24 December 2025 | 2 min read
The Transmitter’s top news articles of 2025
Check out some of our most-read stories, covering neuroscience funding and policy changes in the United States, and methodological issues in high-profile neuroscience papers.
The Transmitter’s top news articles of 2025
Check out some of our most-read stories, covering neuroscience funding and policy changes in the United States, and methodological issues in high-profile neuroscience papers.
By
The Transmitter
24 December 2025 | 3 min read